ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008

Nobel Prize Recognizes Gene Targeting.

October 12, 2007

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

In Brief: Breast Cancer Detection Concept Was For Grants, Not Contracts; Wallens Gets Five Years Probation

November 16, 1984

Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE

October 4, 2002

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992